CSSS-Institut Universitaire Gériatric de Sherbrooke
Sherbrooke, Qubec, Canada
University in Sherbrooke, Quebec
1036 Rue Belvédère S, Sherbrooke, QC J1H 4C4
About CSSS-Institut Universitaire Gériatric de Sherbrooke
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Boehringer Ingelheim
2
Sanofi
1
Université de Sherbrooke
1
Clinical Trials at CSSS-Institut Universitaire Gériatric de Sherbrooke
During the past decade, CSSS-Institut Universitaire Gériatric de Sherbrooke conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2003-11-01
2007-10-01
Completed
1,306
Efficacy and Feasibility of an Intermittent Weight Loss Program.
2005-09-01
2007-06-01
Completed
20
Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo
2015-01-15
2017-10-09
Completed
128
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
2015-01-21
2017-10-10
Completed
329
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CSSS-Institut Universitaire Gériatric de Sherbrooke"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Fonds de la Recherche en Santé du Québec" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at CSSS-Institut Universitaire Gériatric de Sherbrooke
According to Clinical.Site data, the most researched conditions in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are
"Alzheimer Disease" (3 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "CSSS-Institut Universitaire Gériatric de Sherbrooke" in a lesser frequency.
Clinical Trials Intervention Types at CSSS-Institut Universitaire Gériatric de Sherbrooke
Most popular intervention types in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "BI 409306" (2 trials), "Lanabecestat" (2 trials), "Donepezil" (1 trials) and "calorie controlled diet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CSSS-Institut Universitaire Gériatric de Sherbrooke
The vast majority of trials in "CSSS-Institut Universitaire Gériatric de Sherbrooke" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CSSS-Institut Universitaire Gériatric de Sherbrooke
Currently, there are NaN active trials in "CSSS-Institut Universitaire Gériatric de Sherbrooke".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CSSS-Institut Universitaire Gériatric de Sherbrooke,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CSSS-Institut Universitaire Gériatric de Sherbrooke, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".